Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Xanthinol |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Nylidrin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Inositol hexanitrate |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Vascormone |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanethidine monosulfate |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Dioxyline |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Hydralazine hydrochloride |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Trolnitrate phosphate |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Eritrityl tetranitrate |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Khellin |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Beta pyridyl carbinol (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
uklassificeret vasodilaterende middel |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Heptaminol |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Betahistine dihydrochloride |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Perifer/cerebral vasodilatator |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Nitrate-based vasodilating agent (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Tolazoline |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Papaverine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanadrel (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
forgiftning med vasodilatator |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
1 |
Coronary vasodilator poisoning NOS |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Other vasodilator poisoning |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Other vasodilator poisoning NOS |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
forgiftning med koronar vasodilatator |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
1 |
natriumnitroprussid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
intrakavernøs vasodilatator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
intravenøs vasodilatator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
intraarteriel vasodilatator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Accidental diazoxide poisoning |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Intentional diazoxide poisoning |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
forgiftning med diazoxid, uvist med hvilken hensigt |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Accidental dipyridamole poisoning |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Intentional dipyridamole poisoning |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
forgiftning med dipyridamol, uvist med hvilken hensigt |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Accidental nitrite poisoning |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Intentional nitrite poisoning |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
forgiftning med nitrit, uvist med hvilken hensigt |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Vasodilator adverse reaction |
Causative agent |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
1 |
Vasodilator antihypertensive drug adverse reaction |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
bivirkning af natriumnitroprussid |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Flosequinan adverse reaction |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Diazoxide adverse reaction |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Dipyridamole adverse reaction |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Alpha blocking vasodilator adverse reaction |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Thymoxamine adverse reaction (disorder) |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
allergi over for vasodilator |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Vasodilator antihypertensive drug allergy |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
allergi over for natriumnitroprussid |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Allergy to flosequinan (finding) |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Allergy to diazoxide (finding) |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Allergy to dipyridamole (finding) |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Alpha blocking vasodilator allergy |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Allergy to moxisylyte |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Vasodilator overdose |
Causative agent |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
1 |
Diazoxide overdose |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Accidental diazoxide overdose |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Intentional diazoxide overdose (disorder) |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
overdosis af diazoxid, uvist med hvilken hensigt |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Dipyridamole overdose |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Accidental dipyridamole overdose (disorder) |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Intentional dipyridamole overdose |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
overdosis af dipyridamol, uvist med hvilken hensigt |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
kardilaterende antihypertensiva |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Diazoxide [cardiovascular use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
diazoxid 15 mg/ml injektionsvæske, opløsning, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
natriumnitroprussid 10 mg/ml koncentrat til infusionsvæske, 5 ml hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Vasodilators used in angina pectoris |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing flosequinan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Vasodilators in heart failure [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Peripheral vasodilators and related drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing moxisylyte (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Moxisylyte 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Cerebral vasodilators |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Dipyridamole 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Dipyridamole 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
dipyridamol kapsel med modificeret udløsning a 200 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
dipyridamol 5 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing aspirin and dipyridamole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre 25 mg + dipyridamol 200 mg depotkapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
betahistinhydrochlorid 16 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
betahistinhydrochlorid 8 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Poisoning by diazoxide |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Diazoxide [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Diazoxide 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Thymoxamine hydrochloride [erectile dysfunction] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Thymoxamine hydrochloride [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Epinephrine 5 mg/mL and guanethidine monosulfate 30 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Adrenaline 2 mg/mL and guanethidine monosulfate 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
guanethidinmonosulfat 1 % + adrenalin 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
guanethidinmonosulfat 0,5 % + adrenalin 0,1 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
guanethidinmonosulfat 0,25 % + adrenalin 0,05 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
thymoxamin 0,5 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Poisoning by dipyridamole |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing guanethidine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanethidine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
guanethidin øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
alfablokerende vasodilatator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing betahistine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing moxisylyte in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing moxisylyte in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Topical oral thymoxamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|